Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and ...

NORTHAMPTON, MA / ACCESS Newswire / June 23, 2025 / After captivating students across North America and Europe with access to hands-on science, the Curiosity Cube from the Life Science business of Mer ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...

Merck, a leading science and technology company, today announced Neoclease as the winner of the 2025 North American Advance ...

Cohort B of the Phase 2 study indicates all doses of enpatoran were associated with higher BICLA response rates compared with placebo, though the ...

Simtra BioPharma & MilliporeSigma enter strategic alliance for ADC drug substance and drug product manufacturing services: Parsippany, New Jersey Thursday, June 12, 2025, 15:00 Hr ...

Ayesa Engineering, a global provider of engineering and technology services, has been awarded a key specialist advisory ...

DB InfraGO AG, the part of Deutsche Bahn responsible for infrastructure construction, has commissioned Implenia to build a ...

The platform ‘Fertility Unfiltered’ encourages open conversations around fertility, highlighting real stories and practical solutions to support women’s reproductive health ...

The need-to-know this morning. The FDA issued a “refuse-to-file” letter to ImmunityBio, turning back the company’s application to expand the approval of Anktiva, a drug used to treat ...